von Tobias Borgers | Aug. 24, 2019 | Roche
Media Release Basel, 16 May 2019 Roche’s personalised medicine entrectinib shrank tumours harbouring NTRK, ROS1 or ALK gene fusions in children and adolescents Phase I/II study of entrectinib, an investigational medicine, showed responses in all paediatric tumour...
von Tobias Borgers | Aug. 24, 2019 | MSD
Pressemitteilung Elimination von Gebärmutterhalskrebs könnte innerhalb dieses Jahrhunderts möglich sein Haar, 18. April 2019 Gebärmutterhalskrebs könnte schon am Ende dieses Jahrhunderts in den meisten Ländern der Welt unter eine mögliche Eliminierungsschwelle fallen....
von Tobias Borgers | Aug. 24, 2019 | Novartis
Imagine you are born already facing a number of setbacks in life. Imagine you lose out on the health benefits of breastfeeding when you are an infant, because you are the sixth child in the family and your mother has to work because she is struggling to make ends...
von Tobias Borgers | Aug. 24, 2019 | Continuous Manufacturing
The worldwide “Pemetrexed Diacid market” statistical surveying report is an inescapable research report that contacts the most imperative parts of the Pemetrexed Diacid platform that is important to be gotten a handle on by an expert or even a layman. The research...
von Tobias Borgers | Aug. 24, 2019 | Tablet Coating
The Tablet Coating Machines market was valued at XX Million US$ in 2018 and is projected to reach XX Million US$ by 2024, at a CAGR of XX% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2024 as the forecast period to...
